Roivant Sciences (ROIV) Assets (2021 - 2026)
Roivant Sciences' Assets was $5.31 billion in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 5.4% from $5.03 billion a year earlier but down 7.0% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Assets (2021 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Assets at Roivant Sciences came in at $5.71 billion, up 5.0% from FY2025.
- Assets shows a five-year compound annual growth rate of 17.1% (FY2021 to FY2026).
- In earlier fiscal years, Assets was $5.44 billion in FY2025 (-24.7%), $7.22 billion in FY2024 (+202.2%), $2.39 billion in FY2023 (-7.6%) and $2.59 billion in FY2022 (-0.2%).
- Quarterly Assets has moved between $2.07 billion (fiscal Q2 2024) and $7.31 billion (fiscal Q3 2024) over five years.
- Compared with a year earlier, Assets was higher in three of the last eight quarters, with growth averaging 14.3%.
- The best year-over-year quarter for Assets over five years was fiscal Q3 2024 (growth of 231.9%); the worst was fiscal Q2 2023 (a decline of 28.6%).
- Per Business Quant data, ROIV's Assets in the three fiscal quarters before Q1 2027 was $5.71 billion (Q4 2026), $5.23 billion (Q3 2026) and $5.06 billion (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn | 5.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.31 Bn |
| Mar 31, 2026 | 5.71 Bn |
| Dec 31, 2025 | 5.23 Bn |
| Sep 30, 2025 | 5.06 Bn |
| Jun 30, 2025 | 5.03 Bn |
| Mar 31, 2025 | 5.44 Bn |
| Dec 31, 2024 | 5.79 Bn |
| Sep 30, 2024 | 6.21 Bn |
| Jun 30, 2024 | 6.50 Bn |
| Mar 31, 2024 | 7.22 Bn |
| Dec 31, 2023 | 7.31 Bn |
| Sep 30, 2023 | 2.07 Bn |
| Jun 30, 2023 | 2.14 Bn |
| Mar 31, 2023 | 2.39 Bn |
| Dec 31, 2022 | 2.20 Bn |
| Sep 30, 2022 | 2.22 Bn |
| Jun 30, 2022 | 2.60 Bn |
| Mar 31, 2022 | 2.59 Bn |
| Dec 31, 2021 | 2.80 Bn |
| Sep 30, 2021 | 3.10 Bn |
API Access
Roivant Sciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();